14-day Premium Trial Subscription Sign Up For FreeGet Free

Weaker Stock
Today CLLS ranks #14531 as sell candidate. Get a Free Stock at Robinhood
Stronger Stock

Cellectis S.A. Stock Forecast NASDAQ:CLLS

$10.77 (-4.10%)

Volume: 89k

Closed: Oct 22, 2021

Hollow Logo Score: -3.525

Cellectis S.A. Stock Forecast

$10.77 (-4.10%)

Volume: 89k

Closed: Oct 22, 2021

Score Hollow Logo -3.525

Cellectis S.A. Stock Price (Quote) NASDAQ:CLLS

$10.77 ( -4.10% ) Friday, 22nd Oct 2021

Range Low Price High Price Comment
30 days $8.72 $14.17 Friday, 22nd Oct 2021 CLLS stock ended at $10.77. This is 4.1% less than the trading day before Thursday, 21st Oct 2021. During the day the stock fluctuated 4.51% from a day low at $10.65 to a day high of $11.13.
90 days $8.72 $15.50
52 weeks $8.72 $34.71

Historical Cellectis S.A. prices

Date Open High Low Close Volume
2021-10-22 $11.13 $11.13 $10.65 $10.77 88 983
2021-10-21 $11.03 $11.46 $11.03 $11.23 144 701
2021-10-20 $10.92 $11.00 $10.75 $10.94 95 466
2021-10-19 $10.61 $11.25 $10.54 $10.82 264 306
2021-10-18 $10.69 $11.06 $10.41 $10.50 166 420
2021-10-15 $10.54 $10.87 $10.45 $10.83 241 044
2021-10-14 $9.88 $10.84 $9.78 $10.70 585 563
2021-10-13 $9.77 $9.89 $9.33 $9.62 468 487
2021-10-12 $9.15 $9.35 $9.10 $9.15 266 652
2021-10-11 $8.95 $9.21 $8.95 $9.03 334 045
2021-10-08 $10.11 $10.11 $8.72 $9.11 2 180 252
2021-10-07 $12.00 $12.16 $11.84 $12.02 276 102
2021-10-06 $12.23 $12.43 $11.83 $11.97 160 199
2021-10-05 $12.49 $12.89 $12.20 $12.48 104 350
2021-10-04 $12.49 $12.55 $12.07 $12.17 232 230
2021-10-01 $12.62 $12.70 $12.25 $12.69 121 627
2021-09-30 $12.65 $13.12 $12.60 $12.61 141 840
2021-09-29 $13.07 $13.24 $12.37 $12.63 152 457
2021-09-28 $13.63 $13.63 $12.96 $12.96 109 828
2021-09-27 $13.57 $13.74 $13.24 $13.51 98 177
2021-09-24 $13.70 $13.93 $13.22 $13.41 90 034
2021-09-23 $13.85 $13.93 $13.55 $13.81 95 308
2021-09-22 $13.74 $14.17 $13.69 $13.77 110 954
2021-09-21 $13.59 $14.10 $13.51 $13.60 101 749
2021-09-20 $13.87 $14.01 $13.29 $13.50 143 760
2021-09-17 $13.68 $14.49 $13.65 $14.43 171 641
2021-09-16 $13.83 $13.88 $13.51 $13.55 50 388
2021-09-15 $13.80 $14.04 $13.60 $14.00 50 819
2021-09-14 $14.06 $14.24 $13.60 $13.86 74 561
2021-09-13 $14.40 $14.57 $13.87 $14.30 113 178
2021-09-10 $14.76 $14.86 $14.23 $14.26 66 984
2021-09-09 $14.63 $15.24 $14.61 $14.87 89 821
2021-09-08 $14.84 $14.90 $14.21 $14.32 82 444
2021-09-07 $15.36 $15.40 $14.70 $14.99 110 454
2021-09-03 $15.24 $15.47 $15.02 $15.24 111 529
2021-09-02 $15.28 $15.50 $15.07 $15.33 135 844
2021-09-01 $14.88 $15.21 $14.76 $14.92 141 450
2021-08-31 $14.77 $14.81 $14.32 $14.38 146 120
2021-08-30 $14.26 $14.37 $13.86 $13.95 90 029
2021-08-27 $13.81 $14.40 $13.72 $14.27 134 902
2021-08-26 $13.48 $13.87 $13.36 $13.38 71 104
2021-08-25 $13.40 $13.90 $13.16 $13.55 97 774
2021-08-24 $13.48 $13.60 $13.12 $13.27 76 881
2021-08-23 $12.76 $13.72 $12.70 $13.48 222 460
2021-08-20 $11.99 $12.82 $11.94 $12.47 168 018
2021-08-19 $12.47 $12.60 $11.88 $11.94 175 517
2021-08-18 $12.52 $12.95 $12.42 $12.61 111 203
2021-08-17 $12.34 $12.54 $11.93 $12.33 216 773
2021-08-16 $12.52 $12.70 $12.04 $12.59 240 373
2021-08-13 $12.83 $12.89 $12.52 $12.52 101 368

About Cellectis S.A.

Cellectis SA Cellectis S.A., a gene-editing company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. Its lead product candidate is UCART19, an allogeneic T-cell product candidate for the treatment of CD19 expressing hematologic malignancies which develop in acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia. The company’s products also include UCART1... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT